Short supply of Terramycin exposes weak spot of the pharmaceutical notification system
“If a top product of a specific prescription market is not supplied for a year, it must be considered not as out-of-stock, but manufacturing suspension.”
It is a part of the opinions towards the short supply of Pfizer’s Terramycin Eye Oint
Most of all, the biggest problem is that the drug, whic...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
